Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Low grade lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 1
This pilot study is looking at chemotherapy with different doses of Campath as the first treatment for peripheral T cell lymphoma. This trial is supported by Cancer Research UK.
Recruitment start: 15 May 2007
Recruitment end: 31 December 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rod Johnson
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Schering Healthcare Ltd
University College London (UCL)
This is Cancer Research UK trial number CRUKE/04/016.
Last reviewed: 11 December 2013
CRUK internal database number: 546